SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 400.83 |
| Enterprise Value ($M) | 308.86 |
| Book Value ($M) | 343.15 |
| Book Value / Share | 6.46 |
| Price / Book | 1.17 |
| NCAV ($M) | 327.06 |
| NCAV / Share | 6.16 |
| Price / NCAV | 1.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.25 |
| Return on Assets (ROA) | -0.21 |
| Return on Equity (ROE) | -0.22 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 23.81 |
| Current Ratio | 23.81 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 347.46 |
| Assets | 363.56 |
| Liabilities | 20.41 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -104.18 |
| Net Income | -86.48 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -69.77 |
| Cash from Investing | -98.40 |
| Cash from Financing | 202.14 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Ra Capital Management, L.p. | 20.10 | 0.07 | |
| 13G | TCG Crossover GP I, LLC | 5.70 | ||
| 13G/A | Biotechnology Value Fund L P | 7.80 | -15.38 | |
| 13G/A | Canaan XI L.P. | 7.40 | -5.22 | |
| 13D/A | Boxer Capital Management, LLC | 5.00 | -37.40 | |
| 13G/A | Nextech Vi Oncology Scsp | 7.70 | 61.04 | |
| 13G/A | Fmr Llc | 6.39 | -27.53 | |
| 13D/A | Boxer Asset Management Inc. | 0.00 | ||
| 13D/A | Boxer Capital, LLC | 12.40 | 1.33 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| l UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| l UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 23,644 | 188,300 | 12.56 | |
| 65,287 | 390,153 | 16.73 | |
| 450,272 | 1,098,852 | 40.98 | |
| 40,825 | 238,076 | 17.15 | |
| 68,175 | 364,263 | 18.72 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TSVT – 2seventy bio, Inc. | TWST – Twist Bioscience Corporation |
| TXMD – TherapeuticsMD, Inc. | UBX – Unity Biotechnology, Inc. |
| UTHR – United Therapeutics Corporation |
Financial data and stock pages provided by
Fintel.io